Overview

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
NEPA-15-18 is a clinical study assessing safety of pro-netupitant and palonosetron, two antiemetic drugs, given with oral dexamethasone. The objective of the study is to evaluate if pro-netupitant and palonosetron are safe when administered to prevent nausea and vomiting after administration of repeated cycles of chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Helsinn Healthcare SA
Collaborators:
PSI CRO
PSI CRO AG
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Palonosetron